These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9316668)

  • 1. Treatment with botulinum toxin injections does not change brainstem interneuronal excitability in patients with cervical dystonia.
    Valls-Sole J; Tolosa ES; Marti MJ; Allam N
    Clin Neuropharmacol; 1994 Jun; 17(3):229-35. PubMed ID: 9316668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm.
    Valls-Sole J; Tolosa ES; Ribera G
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):310-3. PubMed ID: 1647444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label study of botulinum toxin A for treatment of tardive dystonia.
    Tarsy D; Kaufman D; Sethi KD; Rivner MH; Molho E; Factor S
    Clin Neuropharmacol; 1997 Feb; 20(1):90-3. PubMed ID: 9037579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blink reflex and the masseter inhibitory reflex in patients with dystonia.
    Pauletti G; Berardelli A; Cruccu G; Agostino R; Manfredi M
    Mov Disord; 1993 Oct; 8(4):495-500. PubMed ID: 8232360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based medicine in botulinum toxin therapy for cervical dystonia.
    Ceballos-Baumann AO
    J Neurol; 2001 Apr; 248 Suppl 1():14-20. PubMed ID: 11357233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose botulinum toxin-a treatment of cervical dystonia - a double-blind, randomized pilot study.
    Laubis-Herrmann U; Fries K; Topka H
    Eur Neurol; 2002; 47(4):214-21. PubMed ID: 12037435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications and management of botulinum toxin].
    Singer C
    Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cervical dystonia with botulinum toxin in a patient with myasthenia gravis.
    Gonçalves MR; Barbosa ER; Zambon AA; Marchiori PE
    Arq Neuropsiquiatr; 1999 Sep; 57(3A):683-5. PubMed ID: 10667297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm.
    Quartarone A; Sant'Angelo A; Battaglia F; Bagnato S; Rizzo V; Morgante F; Rothwell JC; Siebner HR; Girlanda P
    J Neurosci; 2006 Jan; 26(2):716-21. PubMed ID: 16407569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia.
    Ansved T; Odergren T; Borg K
    Neurology; 1997 May; 48(5):1440-2. PubMed ID: 9153487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of mirror dystonia as guidance for injection of botulinum toxin in writing dysfunction.
    Singer C; Papapetropoulos S; Vela L
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1608-9. PubMed ID: 16227568
    [No Abstract]   [Full Text] [Related]  

  • 13. Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A.
    Teive HA; Klüppel LE; Munhoz RP; Becker N; Müller PR; Werneck LC
    Arq Neuropsiquiatr; 2012 Jun; 70(6):407-9. PubMed ID: 22699536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Botulinum A toxin in the treatment of focal dystonias].
    Domzał TM
    Neurol Neurochir Pol; 1998; 32 Suppl 1():35-44. PubMed ID: 9608551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin A for patients with orofacial dystonia: prospective, observational, single-centre study.
    Ruiz-de-León-Hernández G; Díaz-Sánchez RM; Torres-Lagares D; Hernández-Pacheco E; González-Martín M; Serrera-Figallo MA
    Int J Oral Maxillofac Surg; 2018 Mar; 47(3):386-391. PubMed ID: 29208327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurophysiological investigations in patients with head tremor.
    Valls-Solé J; Tolosa ES; Nobbe F; Diéguez E; Muñoz E; Sanz P; Valldeoriola F
    Mov Disord; 1997 Jul; 12(4):576-84. PubMed ID: 9251077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative electromyography-guided botulinum toxin treatment of cervical dystonia.
    Finsterer J; Fuchs I; Mamoli B
    Clin Neuropharmacol; 1997 Feb; 20(1):42-8. PubMed ID: 9037572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological studies in patients with blepharospasm before and after botulinum toxin A therapy.
    Behari M; Raju GB
    J Neurol Sci; 1996 Jan; 135(1):74-7. PubMed ID: 8926500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.